CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

dabrafenib/trametinib

Phase 2
Novartis AG (NVS)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jan '27
NVSPhase 2

dabrafenib/trametinib Phase 2 Est. Readout

dabrafenib/trametinib
Jan 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Anaplastic Thyroid Cancer

View Full Landscape
Drug Information

Target Indication

Anaplastic Thyroid Cancer

Clinical Trial

NCT06079333

Last updated: 9/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.